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PURPOSE  
The production of co-amorphous mixtures has gained special relevance within the pharmaceutical 
industry since it allows to overcome the poor water solubility presented by most drugs (70-90%) [1] 
currently under research and development. Co-amorphous are defined as single phase mixtures of 
more than one compound that, due to e.g. the establishment of molecular bonds between the 
particles, prevents the recrystallization process [2]. The purpose of this work was the production 
and characterization of a stable co-amorphous mixture of olanzapine, a BCS class II antipsychotic. 
METHODS 
A mixture comprising olanzapine and saccharin in a 1:1 molar ratio was dissolved in 
dichloromethane and then the co-amorphization was carried out by solvent evaporation. The 
characterization of the material was achieved by differential scanning calorimetry (DSC), X-ray 
powder diffraction (XRPD) and Fourier-transform infrared spectroscopy (FTIR).  
RESULTS 
DSC confirmed the production of a co-amorphous mixture of olanzapine and saccharin, which was 
further validated using XRPD. FTIR analysis indicated the establishment of an intermolecular bond 
between the two compounds used, which in turn justifies the stability of the co-amorphous entity. 
Olanzapine solubility in water increased 114 times. 
CONCLUSION 
Solvent evaporation of a mixture of olanzapine and saccharine resulted in the production of a stable 
co-amorphous, promoting the water solubility of the drug.  
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